NCT04554914 2026-02-20A Study to Evaluate Tabelecleucel in Participants With Epstein Barr Virus (EBV) Associated DiseasesPierre Fabre MedicamentPhase 2 Recruiting190 enrolled
NCT02822495 2023-06-15Expanded Access Protocol for Tabelecleucel for Patients With Epstein-Barr Virus-Associated Viremia or MalignanciesAtara BiotherapeuticsNo longer available